Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

1.

Biotherapy with the pineal immunomodulating hormone melatonin versus melatonin plus aloe vera in untreatable advanced solid neoplasms.

Lissoni P, Giani L, Zerbini S, Trabattoni P, Rovelli F.

Nat Immun. 1998;16(1):27-33.

PMID:
9789122
[PubMed - indexed for MEDLINE]
2.

Cord blood-derived cytokine-induced killer cells biotherapy combined with second-line chemotherapy in the treatment of advanced solid malignancies.

Niu Q, Wang W, Li Y, Qin S, Wang Y, Wan G, Guan J, Zhu W.

Int Immunopharmacol. 2011 Apr;11(4):449-56. doi: 10.1016/j.intimp.2010.12.014. Epub 2011 Jan 5.

PMID:
21215350
[PubMed - indexed for MEDLINE]
3.

Rationale for combining biotherapy in the treatment of advanced colon cancer.

Cohen DJ, Hochster HS.

Gastrointest Cancer Res. 2008 May;2(3):145-51.

PMID:
19259292
[PubMed]
Free PMC Article
4.

Combination biotherapy utilizing interleukin-2 and alpha interferon in patients with advanced cancer: a National Biotherapy Study Group Trial.

Oldham RK, Blumenschein G, Schwartzberg L, Birch R, Arnold J.

Mol Biother. 1992 Mar;4(1):4-9.

PMID:
1627272
[PubMed - indexed for MEDLINE]
5.

Continuous infusion of interleukin-2 and cyclophosphamide as treatment of advanced cancers: a National Biotherapy Study Group Trial.

Oldham RK, Stark J, Barth NM, Hoogstraten B, Brown CH, O'Connor T, Dupere S, Birch R.

Mol Biother. 1991 Jun;3(2):74-8.

PMID:
1910623
[PubMed - indexed for MEDLINE]
6.

[Biotherapy of advanced cancer by infusion of in vitro activated autolymphocytes].

Du X, Zhang M, Zhao M.

Zhonghua Zhong Liu Za Zhi. 1995 Nov;17(6):464-6. Chinese.

PMID:
8698005
[PubMed - indexed for MEDLINE]
8.

Continuous interleukin-2 and tumor-infiltrating lymphocytes as treatment of advanced melanoma. A national biotherapy study group trial.

Dillman RO, Oldham RK, Barth NM, Cohen RJ, Minor DR, Birch R, Yannelli JR, Maleckar JR, Sferruzza A, Arnold J, et al.

Cancer. 1991 Jul 1;68(1):1-8.

PMID:
2049729
[PubMed - indexed for MEDLINE]
9.

Short-duration in vitro interleukin-2-activated mononuclear cells for advanced cancer. A Hong Kong biotherapy pilot study trial.

Yeung AW, Pang YK, Tsang YC, Wong SW, Leung JS.

Cancer. 1993 Jun 1;71(11):3633-9.

PMID:
8387882
[PubMed - indexed for MEDLINE]
10.

Interferon-alpha and chemohormonal therapy for patients with advanced melanoma: final results of a phase I-II study of the Cancer Biotherapy Research Group and the Mid-Atlantic Oncology Program.

Stark JJ, Dillman RO, Schulof R, Wiemann MC, Barth NM, Honeycutt PJ, Soori G.

Cancer. 1998 May 1;82(9):1677-81.

PMID:
9576288
[PubMed - indexed for MEDLINE]
11.

Continuous interleukin-2 and lymphokine-activated killer cells for advanced cancer: a National Biotherapy Study Group trial.

Dillman RO, Oldham RK, Tauer KW, Orr DW, Barth NM, Blumenschein G, Arnold J, Birch R, West WH.

J Clin Oncol. 1991 Jul;9(7):1233-40.

PMID:
2045864
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk